Please use this identifier to cite or link to this item:
Title: CGRP en migraña: de la fisiopatología a la terapéutica
Filiation: Servicio de Medicina Interna. Neurología. Hospital Universitario de Fuenlabrada.
Issue Date: 17-Jul-2019
Publisher: Elsevier BV
Citation: Santos-Lasaosa S, Belvís R, Cuadrado ML, Díaz-Insa S, Gago-Veiga A, Guerrero-Peral AL, Huerta M, Irimia P, Láinez JM, Latorre G, Leira R, Pascual J, Porta-Etessam J, Sánchez Del Río M, Viguera J, Pozo-Rosich P. Calcitonin gene-related peptide in migraine: from pathophysiology to treatment. Neurologia (Engl Ed). 2019 Jul 17:S0213-4853(19)30075-1. English, Spanish. doi: 10.1016/j.nrl.2019.03.013. Epub ahead of print. PMID: 31326215.
Abstract: It has been observed in recent years that levels of such molecules as calcitonin gene-related peptide (CGRP) and, to a lesser extent, the pituitary adenylate cyclase-activating peptide are elevated during migraine attacks and in chronic migraine, both in the cerebrospinal fluid and in the serum. Pharmacological reduction of these proteins is clinically significant, with an improvement in patients' migraines. It therefore seems logical that one of the main lines of migraine research should be based on the role of CGRP in the pathophysiology of this entity.
PMID: 31326215
Rights: info:eu-repo/semantics/openAccess
Atribución-NoComercial-SinDerivadas 3.0 España
ISSN: 0213-4853
Appears in Collections:Hospitales > H. U. de Fuenlabrada > Artículos

Files in This Item:
File Description SizeFormat 
Neurologia español.pdf563.12 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons